- Release Date: 08/09/22 08:54
- Summary: Imugene doses first patient in nextHERIZON Phase 2 trial
- Price Sensitive: Yes
- Download Document 191.8KB
- Forums
- ASX - By Stock
- Ann: Imugene doses first patient in nextHERIZON Phase 2 trial
Ann: Imugene doses first patient in nextHERIZON Phase 2 trial
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.4¢ |
Change
-0.001(0.93%) |
Mkt cap ! $382.1M |
Open | High | Low | Value | Volume |
5.3¢ | 5.4¢ | 5.2¢ | $278.4K | 5.273M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 558279 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 1434436 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 558279 | 0.053 |
25 | 2362524 | 0.052 |
40 | 4412279 | 0.051 |
48 | 4495081 | 0.050 |
18 | 2268068 | 0.049 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 1434436 | 15 |
0.055 | 1254194 | 15 |
0.056 | 2908881 | 19 |
0.057 | 1412278 | 14 |
0.058 | 840000 | 7 |
Last trade - 12.46pm 15/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online